Evidence map›Paper›PMID 36133427›Full record

ArticleRevista panamericana de salud publica = Pan American journal of public health2022

[Impact of the HEARTS Initiative in a second-level health institution in ColombiaImpacto da iniciativa HEARTS em um estabelecimento de atenção secundária à saúde na Colômbia].

Sofía Rivas Rivas, Danna Camila Serna Tobón, Karol Yuliana Mahecha Gallego, María Paula Tejada Cardona, Juan Daniel Castrillón Spitia, Paula Andrea Moreno Gutierrez, Alexandra Agudelo Ramírez

Open access · diamondAbstract readEnglish Abstract
In one paragraph

Article in Revista panamericana de salud publica = Pan American journal of public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Sofía Rivas RivasInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
Danna Camila Serna TobónInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
Karol Yuliana Mahecha GallegoInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
María Paula Tejada CardonaInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
Juan Daniel Castrillón SpitiaGrupo de Investigación en Farmacoepidemiología y Farmacovigilancia Universidad Tecnológica de Pereira-Audifarma S. A. Pereira Colombia Grupo de Investigación en Farmacoepidemiología y Farmacovigilancia Universidad Tecnológica de Pereira-Audifarma S. A. Pereira, Colombia.
Paula Andrea Moreno GutierrezInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
Alexandra Agudelo RamírezInstitución Universitaria Visión de las Américas Pereira Colombia Institución Universitaria Visión de las Américas, Pereira, Colombia.
Fundación Universitaria Autónoma De Las Américas · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To identify the impact of the HEARTS initiative on patients with high blood pressure treated in a Colombian hospital. Methods: Quasi-experimental, retrospective study between 2017 and 2019 with hypertensive patients over 18 years of age included in the HEARTS strategy and treated at the Santa Mónica Hospital in the municipality of Dosquebradas, department of Risaralda. The unit of analysis was medical history. Blood pressure targets (defined in the HEARTS initiative as a patient with systolic blood pressure <140 mmHg and diastolic pressure <90 mmHg) were assessed at the time of admission to the HEARTS program and one year later. Sociodemographic, pharmacological, clinical, and blood pressure targets were included, as was compliance with the recommendations of the initiative. Descriptive analysis was performed, and binary logistic regression was applied (p <0.05). Results: A total of 372 patients were studied, of whom 262 were women (70.4%). The mean age was 66.3 ± 12.2 years. In the first consultation, 285 patients (76.6%) presented blood pressure figures within the target range; in the second consultation this was achieved by 84.1% of patients (n=313, mean difference: 7.5%, 95% CI: 1.8 to 13.1; p=0.005). After implementation of the HEARTS initiative, 77.4% of patients (n=288) continued with the initial treatment. Following HEARTS recommendations increases the likelihood of being in the target range (p=0.033; OR= 2,688; CI= 1.081 - 6.684). Conclusions: Implementation of the HEARTS initiative favorably impacted blood pressure figures in patients with hypertension and decreased cardiovascular risk.

Indexed as

Colombiahealth strategiesHypertensionoutcome and process assessment, health carepublic health

Identifiers

PMID36133427
PMCPMC9484327
OpenAlexW4296271598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.